Sphere（A347700）株式概要スフィア社はデジタルヘルスケア技術、ライフケア製品・サービスを提供している。 詳細A347700 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績4/6財務の健全性1/6配当金0/6報酬過去1年間で収益は602%増加しました リスク分析高いレベルの非現金収入 KR市場と比較して、過去 3 か月間の株価の変動が非常に大きい利払いは収益で十分にカバーされない 過去1年間で株主の希薄化は大幅に進んだ すべてのリスクチェックを見るA347700 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW489,752 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA489,752 investors already sharing narrativesYour Fair Value₩Current Price₩14.81k474.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-4b119b2016201920222025202620282031Revenue ₩118.9bEarnings ₩43.0bAdvancedSet Fair ValueView all narrativesSphere Corp. 競合他社INFINITT HealthcareSymbol: KOSDAQ:A071200Market cap: ₩188.7bGC MediAISymbol: KOSDAQ:A032620Market cap: ₩145.2bezCaretechSymbol: KOSDAQ:A099750Market cap: ₩86.6bBIT ComputerSymbol: KOSDAQ:A032850Market cap: ₩60.4b価格と性能株価の高値、安値、推移の概要Sphere過去の株価現在の株価₩14,810.0052週高値₩57,300.0052週安値₩7,050.00ベータ0.761ヶ月の変化-14.39%3ヶ月変化-63.52%1年変化39.59%3年間の変化197.69%5年間の変化-10.24%IPOからの変化-15.37%最新ニュースValuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,300, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 341% over the past three years.分析記事 • Jul 10With EPS Growth And More, Sphere (KOSDAQ:347700) Makes An Interesting CaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩35,200, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 713% over the past three years.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩33,450, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 678% over the past three years.New Risk • May 31New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (44% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding).New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (45% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Profit margins are more than 30% lower than last year (4.6% net profit margin).最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,300, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 341% over the past three years.分析記事 • Jul 10With EPS Growth And More, Sphere (KOSDAQ:347700) Makes An Interesting CaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩35,200, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 713% over the past three years.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩33,450, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 678% over the past three years.New Risk • May 31New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (44% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding).New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (45% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Profit margins are more than 30% lower than last year (4.6% net profit margin).お知らせ • Apr 23Sphere Corp. announced that it expects to receive KRW 37.5 billion in funding from History Investment Co., Ltd.Sphere Corp. has announced a private placement of Series 6 unsecured private placement convertible bonds with warrants of the company to raise gross proceeds of KRW 37,500,000,000 on April 22, 2026. The transaction involves new investor participation of History Investment Co., Ltd. for KRW 4,000,000,000, MVP Innovative Growth PEF for 25,000,000,000, KB Securities Co., Ltd. for 2,000,000,000 and other investors. The Bonds are 100% convertible into 834,650 common shares of the company at a conversion price value of KRW 44,929 and carry interest rate of 0% and maturity interest rate of 0%. The conversion billing period starts from April 30, 2027 to March 30, 2031.The transaction has been approved by the board of directors of the company. The transaction is subject to 1 year hold period. The Bonds have a maturity date of April 30, 2031. The transaction is expected to close on April 30, 2026.New Risk • Apr 12New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). High level of non-cash earnings (45% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.6% net profit margin). Shareholders have been diluted in the past year (18% increase in shares outstanding).分析記事 • Mar 27Sphere's (KOSDAQ:347700) Shareholders Have More To Worry About Than Only Soft EarningsThe latest earnings report from Sphere Corp. ( KOSDAQ:347700 ) disappointed investors. Our analysis suggests that while...お知らせ • Mar 13Sphere Corp., Annual General Meeting, Mar 26, 2026Sphere Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 406, teheran-ro, gangnam-gu, seoul South Koreaお知らせ • Jan 07Sphere Corp. announced that it expects to receive KRW 25 billion in fundingSphere Corp. announced a private placement to issue 1% Series 5 Bearer Convertible Bonds with Unsecured Warrants due January 30, 2029 for gross proceeds of KRW 25,000,000,000 on January 5, 2026. The transaction will include participation from new investor Baekruta Co., Ltd.. The transaction has been approved by shareholders, expected to close on January 30, 2026, restricted to a hold period, bears 1% coupon rate, 2% maturity rate, matures on January 29, 2029, 100% convertible into 1,758,953 common shares at a fixed conversion price of KRW 14,213 from January 30, 2027 to December 30, 2028.New Risk • Dec 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Profit margins are more than 30% lower than last year (-4,415% net profit margin).Valuation Update With 7 Day Price Move • Dec 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,320, the stock trades at a trailing P/E ratio of 77.7x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 88% over the past three years.New Risk • Nov 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: -4,415% Last year net profit margin: 7.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Profit margins are more than 30% lower than last year (-4,415% net profit margin).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩8,950, the stock trades at a trailing P/E ratio of 40.6x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 132% over the past three years.Valuation Update With 7 Day Price Move • Oct 29Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,040, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 121% over the past three years.New Risk • Aug 31New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (61% accrual ratio). Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Revenue is less than US$1m.Buy Or Sell Opportunity • Aug 22Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 13% to ₩11,480. The fair value is estimated to be ₩9,535, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.New Risk • Aug 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 83% over the past year. Shareholders have been substantially diluted in the past year (135% increase in shares outstanding). Minor Risk Revenue is less than US$5m (₩3.8b revenue, or US$2.7m).Buy Or Sell Opportunity • Jul 31Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to ₩10,900. The fair value is estimated to be ₩8,424, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.Buy Or Sell Opportunity • Jul 09Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 41% to ₩10,360. The fair value is estimated to be ₩8,417, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.Buy Or Sell Opportunity • Jun 17Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to ₩10,310. The fair value is estimated to be ₩8,536, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.分析記事 • Jun 02Is Sphere (KOSDAQ:347700) Weighed On By Its Debt Load?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • May 31New major risk - Revenue and earnings growthRevenue has declined by 83% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 83% over the past year. Shareholders have been substantially diluted in the past year (131% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (₩3.8b revenue, or US$2.7m).Reported Earnings • Mar 20Full year 2024 earnings released: ₩778 loss per share (vs ₩1,065 loss in FY 2023)Full year 2024 results: ₩778 loss per share. Net loss: ₩13.6b (loss widened 22% from FY 2023).お知らせ • Mar 11LifeSemantics Corp., Annual General Meeting, Mar 25, 2025LifeSemantics Corp., Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 406, teheran-ro, gangnam-gu, seoul South Koreaお知らせ • Mar 07LifeSemantics Corp. announced that it has received KRW 15 billion in funding from Widwin Investment Co., Ltd.On March 7, 2025, LifeSemantics Corp. closed the transaction.New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 30% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩90.4b market cap, or US$62.0m).お知らせ • Jan 01LifeSemantics Corp. announced that it has received KRW 4.30251 billion in fundingOn December 30, 2024, LifeSemantics Corp. closed the transaction.New Risk • Nov 28New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩6.9b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Minor Risks Less than 3 years of financial data is available. Revenue is less than US$5m (₩6.9b revenue, or US$5.0m). Market cap is less than US$100m (₩71.7b market cap, or US$51.4m).お知らせ • Oct 22LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 999.99768 million.LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 999.99768 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 387,596 Price\Range: KRW 2580 Transaction Features: Subsequent Direct Listingお知らせ • Sep 05+ 1 more updateGeo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 Completed the acquisition of 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae.Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 agreed to acquire 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae for KRW 11.2 billion on July 22, 2024. A cash consideration of KRW 11.16 billion valued at KRW 3530 per share will be paid by Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1. As part of consideration, KRW 11.16 billion is paid towards common equity of LifeSemantics Corp. The expected completion of the transaction is September 3, 2024. Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 Completed the acquisition of 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae on September 3, 2024.お知らせ • Apr 19LifeSemantics Corp. announced that it expects to receive KRW 2.000001535 billion in fundingLifeSemantics Corp. announced a private placement to issue 997,507 common shares at an issue price of KRW 2,005 per share for the gross proceeds of KRW 2,000,001,535 on April 17, 2024. The transaction will include participation from individual investor Seungjae Song. The transaction has been approved by the shareholders and is restricted to a hold period and is expected to close on May 7, 2024.お知らせ • Feb 29An undisclosed buyer agreed to acquire 10.04% stake in Medistaff Co., Ltd. from LifeSemantics Corp. (KOSDAQ:A347700) for KRW 1.2 billion.An undisclosed buyer agreed to acquire 10.04% stake in Medistaff Co., Ltd. from LifeSemantics Corp. (KOSDAQ:A347700) for KRW 1.2 billion on February 28, 2024. The consideration consists of KRW 1217.9 million in cash. As part of the consideration, KRW 1217.9 million was paid towards common equity. The transaction is expected to complete on March 6, 2024.New Risk • Jan 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩30.5b market cap, or US$22.7m).New Risk • Jan 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 39% over the past year. Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩35.6b market cap, or US$27.2m).お知らせ • Dec 08LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.900303 billion.LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.900303 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,436,560 Price\Range: KRW 2005 Discount Per Security: KRW 30.075 Transaction Features: Rights OfferingNew Risk • Sep 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Revenue has declined by 39% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩45.1b market cap, or US$34.0m).New Risk • Sep 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 39% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩48.0b market cap, or US$36.2m).株主還元A347700KR Healthcare ServicesKR 市場7D-16.0%-1.7%3.5%1Y39.6%-34.5%98.4%株主還元を見る業界別リターン: A347700過去 1 年間で-34.5 % の収益を上げたKR Healthcare Services業界を上回りました。リターン対市場: A347700は、過去 1 年間で98.4 % のリターンを上げたKR市場を下回りました。価格変動Is A347700's price volatile compared to industry and market?A347700 volatilityA347700 Average Weekly Movement21.1%Healthcare Services Industry Average Movement9.9%Market Average Movement9.5%10% most volatile stocks in KR Market17.0%10% least volatile stocks in KR Market5.0%安定した株価: A347700の株価は、 KR市場と比較して過去 3 か月間で変動しています。時間の経過による変動: A347700の weekly volatility ( 21% ) は過去 1 年間安定していますが、依然としてKRの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト201227Kwang Soo Choispherecorp.krスフィア社はデジタルヘルスケア技術、ライフケア製品・サービスを提供。医療記録、ゲノムデータ、個人で作成した健康データなどの健康関連データを管理する商用パーソナルヘルスレコードプラットフォーム「LifeRecord」を開発している。また、非対面治療、服薬管理、健康管理などの消費者向けデジタルヘルスケアサービスや、デジタル治療薬や人工知能技術を用いたソフトウェアベースの医療機器からなるデジタルヘルスイネーブルメントによる患者コミュニティも提供している。さらに、家庭で使用される消費者向け医療機器、医療施設で使用される医療機器や設備、その他の消費財も提供している。以前はライフセマンティクス社として知られていたが、2025年4月にスフィア社に社名変更した。同社は2012年に設立され、韓国のソウルに本社を置いている。もっと見るSphere Corp. 基礎のまとめSphere の収益と売上を時価総額と比較するとどうか。A347700 基礎統計学時価総額₩735.96b収益（TTM）₩42.95b売上高(TTM)₩118.86b17.1xPER（株価収益率6.2xP/SレシオA347700 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A347700 損益計算書（TTM）収益₩118.86b売上原価₩100.70b売上総利益₩18.16bその他の費用-₩24.79b収益₩42.95b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）864.31グロス・マージン15.28%純利益率36.14%有利子負債／自己資本比率334.9%A347700 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/28 17:50終値2026/07/28 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sphere Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,300, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 341% over the past three years.
分析記事 • Jul 10With EPS Growth And More, Sphere (KOSDAQ:347700) Makes An Interesting CaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩35,200, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 713% over the past three years.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩33,450, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 678% over the past three years.
New Risk • May 31New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (44% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding).
New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (45% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Profit margins are more than 30% lower than last year (4.6% net profit margin).
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,300, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 341% over the past three years.
分析記事 • Jul 10With EPS Growth And More, Sphere (KOSDAQ:347700) Makes An Interesting CaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩35,200, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 713% over the past three years.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩33,450, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 678% over the past three years.
New Risk • May 31New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (44% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding).
New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (45% accrual ratio). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Profit margins are more than 30% lower than last year (4.6% net profit margin).
お知らせ • Apr 23Sphere Corp. announced that it expects to receive KRW 37.5 billion in funding from History Investment Co., Ltd.Sphere Corp. has announced a private placement of Series 6 unsecured private placement convertible bonds with warrants of the company to raise gross proceeds of KRW 37,500,000,000 on April 22, 2026. The transaction involves new investor participation of History Investment Co., Ltd. for KRW 4,000,000,000, MVP Innovative Growth PEF for 25,000,000,000, KB Securities Co., Ltd. for 2,000,000,000 and other investors. The Bonds are 100% convertible into 834,650 common shares of the company at a conversion price value of KRW 44,929 and carry interest rate of 0% and maturity interest rate of 0%. The conversion billing period starts from April 30, 2027 to March 30, 2031.The transaction has been approved by the board of directors of the company. The transaction is subject to 1 year hold period. The Bonds have a maturity date of April 30, 2031. The transaction is expected to close on April 30, 2026.
New Risk • Apr 12New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). High level of non-cash earnings (45% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.6% net profit margin). Shareholders have been diluted in the past year (18% increase in shares outstanding).
分析記事 • Mar 27Sphere's (KOSDAQ:347700) Shareholders Have More To Worry About Than Only Soft EarningsThe latest earnings report from Sphere Corp. ( KOSDAQ:347700 ) disappointed investors. Our analysis suggests that while...
お知らせ • Mar 13Sphere Corp., Annual General Meeting, Mar 26, 2026Sphere Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 406, teheran-ro, gangnam-gu, seoul South Korea
お知らせ • Jan 07Sphere Corp. announced that it expects to receive KRW 25 billion in fundingSphere Corp. announced a private placement to issue 1% Series 5 Bearer Convertible Bonds with Unsecured Warrants due January 30, 2029 for gross proceeds of KRW 25,000,000,000 on January 5, 2026. The transaction will include participation from new investor Baekruta Co., Ltd.. The transaction has been approved by shareholders, expected to close on January 30, 2026, restricted to a hold period, bears 1% coupon rate, 2% maturity rate, matures on January 29, 2029, 100% convertible into 1,758,953 common shares at a fixed conversion price of KRW 14,213 from January 30, 2027 to December 30, 2028.
New Risk • Dec 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Profit margins are more than 30% lower than last year (-4,415% net profit margin).
Valuation Update With 7 Day Price Move • Dec 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,320, the stock trades at a trailing P/E ratio of 77.7x. Average trailing P/E is 8x in the Healthcare Services industry in South Korea. Total returns to shareholders of 88% over the past three years.
New Risk • Nov 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: -4,415% Last year net profit margin: 7.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (82% accrual ratio). Shareholders have been substantially diluted in the past year (74% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Profit margins are more than 30% lower than last year (-4,415% net profit margin).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩8,950, the stock trades at a trailing P/E ratio of 40.6x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 132% over the past three years.
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,040, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 9x in the Healthcare Services industry in South Korea. Total returns to shareholders of 121% over the past three years.
New Risk • Aug 31New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (61% accrual ratio). Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Revenue is less than US$1m.
Buy Or Sell Opportunity • Aug 22Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 13% to ₩11,480. The fair value is estimated to be ₩9,535, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.
New Risk • Aug 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 83% over the past year. Shareholders have been substantially diluted in the past year (135% increase in shares outstanding). Minor Risk Revenue is less than US$5m (₩3.8b revenue, or US$2.7m).
Buy Or Sell Opportunity • Jul 31Now 29% overvalued after recent price riseOver the last 90 days, the stock has risen 14% to ₩10,900. The fair value is estimated to be ₩8,424, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.
Buy Or Sell Opportunity • Jul 09Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 41% to ₩10,360. The fair value is estimated to be ₩8,417, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.
Buy Or Sell Opportunity • Jun 17Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 31% to ₩10,310. The fair value is estimated to be ₩8,536, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 83% over the last year. Earnings per share has declined by 209%.
分析記事 • Jun 02Is Sphere (KOSDAQ:347700) Weighed On By Its Debt Load?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • May 31New major risk - Revenue and earnings growthRevenue has declined by 83% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 83% over the past year. Shareholders have been substantially diluted in the past year (131% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (₩3.8b revenue, or US$2.7m).
Reported Earnings • Mar 20Full year 2024 earnings released: ₩778 loss per share (vs ₩1,065 loss in FY 2023)Full year 2024 results: ₩778 loss per share. Net loss: ₩13.6b (loss widened 22% from FY 2023).
お知らせ • Mar 11LifeSemantics Corp., Annual General Meeting, Mar 25, 2025LifeSemantics Corp., Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 406, teheran-ro, gangnam-gu, seoul South Korea
お知らせ • Mar 07LifeSemantics Corp. announced that it has received KRW 15 billion in funding from Widwin Investment Co., Ltd.On March 7, 2025, LifeSemantics Corp. closed the transaction.
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 30% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Minor Risks Revenue is less than US$5m (₩6.9b revenue, or US$4.8m). Market cap is less than US$100m (₩90.4b market cap, or US$62.0m).
お知らせ • Jan 01LifeSemantics Corp. announced that it has received KRW 4.30251 billion in fundingOn December 30, 2024, LifeSemantics Corp. closed the transaction.
New Risk • Nov 28New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₩6.9b (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Minor Risks Less than 3 years of financial data is available. Revenue is less than US$5m (₩6.9b revenue, or US$5.0m). Market cap is less than US$100m (₩71.7b market cap, or US$51.4m).
お知らせ • Oct 22LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 999.99768 million.LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 999.99768 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 387,596 Price\Range: KRW 2580 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 05+ 1 more updateGeo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 Completed the acquisition of 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae.Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 agreed to acquire 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae for KRW 11.2 billion on July 22, 2024. A cash consideration of KRW 11.16 billion valued at KRW 3530 per share will be paid by Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1. As part of consideration, KRW 11.16 billion is paid towards common equity of LifeSemantics Corp. The expected completion of the transaction is September 3, 2024. Geo Energy Link Co., Ltd. and Lucky W New Technology Investment Fund No. 1 Completed the acquisition of 19.97% stake in LifeSemantics Corp. (KOSDAQ:A347700) from Song Seung Jae on September 3, 2024.
お知らせ • Apr 19LifeSemantics Corp. announced that it expects to receive KRW 2.000001535 billion in fundingLifeSemantics Corp. announced a private placement to issue 997,507 common shares at an issue price of KRW 2,005 per share for the gross proceeds of KRW 2,000,001,535 on April 17, 2024. The transaction will include participation from individual investor Seungjae Song. The transaction has been approved by the shareholders and is restricted to a hold period and is expected to close on May 7, 2024.
お知らせ • Feb 29An undisclosed buyer agreed to acquire 10.04% stake in Medistaff Co., Ltd. from LifeSemantics Corp. (KOSDAQ:A347700) for KRW 1.2 billion.An undisclosed buyer agreed to acquire 10.04% stake in Medistaff Co., Ltd. from LifeSemantics Corp. (KOSDAQ:A347700) for KRW 1.2 billion on February 28, 2024. The consideration consists of KRW 1217.9 million in cash. As part of the consideration, KRW 1217.9 million was paid towards common equity. The transaction is expected to complete on March 6, 2024.
New Risk • Jan 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩30.5b market cap, or US$22.7m).
New Risk • Jan 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 39% over the past year. Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩35.6b market cap, or US$27.2m).
お知らせ • Dec 08LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.900303 billion.LifeSemantics Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.900303 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,436,560 Price\Range: KRW 2005 Discount Per Security: KRW 30.075 Transaction Features: Rights Offering
New Risk • Sep 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Revenue has declined by 39% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩45.1b market cap, or US$34.0m).
New Risk • Sep 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 39% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (₩2.8b revenue, or US$2.1m). Market cap is less than US$100m (₩48.0b market cap, or US$36.2m).
